Serum Uric Acid Levels as an Indicator for Metabolically Unhealthy Obesity in Children and Adolescents

被引:40
作者
Rocha, Edrienny Patricia Alves Accioly [1 ,2 ]
Vogel, Mandy [1 ,3 ]
Stanik, Juraj [3 ,4 ,5 ]
Pietzner, Diana [1 ,2 ]
Willenberg, Anja [7 ]
Koerner, Antje [6 ]
Kiess, Wieland [1 ,2 ]
机构
[1] Univ Leipzig, LIFE Child Leipzig Res Ctr Civilizat Dis, Leipzig, Germany
[2] Univ Leipzig, Hosp Children & Adolescents, Liebigstr 20a, DE-04103 Leipzig, Germany
[3] Univ Leipzig, Ctr Paediat Res CPL, Leipzig, Germany
[4] Comenius Univ, Med Fac, Dept Pediat, Bratislava, Slovakia
[5] Slovak Acad Sci, Inst Expt Endocrinol, Biomed Res Ctr, Bratislava, Slovakia
[6] Univ Leipzig, Univ Hosp, Dept Women & Child Hlth, Hosp Children & Adolescents, Leipzig, Germany
[7] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost ILM, Leipzig, Germany
来源
HORMONE RESEARCH IN PAEDIATRICS | 2018年 / 90卷 / 01期
关键词
Metabolically healthy obesity; Metabolically unhealthy obesity; Uric acid; Children; Obesity; CARDIOMETABOLIC RISK-FACTORS; HEALTHY OBESITY; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; C-PEPTIDE; PREVALENCE; CHILDHOOD; INDIVIDUALS; ASSOCIATION; PHENOTYPE;
D O I
10.1159/000490113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Metabolically healthy obesity (MHO) refers to those individuals who do not show cardiometabolic abnormalities. Our aim was to identify potential clinical and metabolic indicators that may help to distinguish between metabolically healthy and unhealthy individuals amongst overweight and obese children and adolescents. Methods: The study involved 246 overweight/obese and 212 normalweight individuals enrolled in the LIFE Child study, aged between 6 and 18 years. Overweight/obese individuals without cardiovascular risk factors (fasting serum lipids, blood pressure, and glucose) were classified as MHO. Individuals meeting 1 or more criteria of cardiovascular risk factors were classified as metabolically unhealthy obesity (MUO). Results: Among the 246 overweight/obese individuals, 173 (70%) were MHO and 73 (30%) were MUO. The MHO individuals were younger, more likely to be male, and had lower BMISDS. In the logistic regression models, uric acid (UA) SDS (OR 1.61, 95% CI 1.1-2.6, p = 0.004), waist circumference SDS (OR 2.50, 95% CI 1.2-6.4, p = 0.017), and C-peptide (OR 4.05, 95% CI 3.5-91, p = 0.003) were significant indicators of MUO. Conclusion: Our results suggest that nearly one-third of overweight/obese children are already identified as MUO. Serum levels of UA can be used as an indicator of unhealthy obesity in youth, where lower levels of UA indicate a lower risk and higher levels suggest a higher risk of MUO. We note that the relevance of identifying potential indicators remains the first most important step in future clinical research. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:19 / 27
页数:9
相关论文
共 52 条
[1]   C-Peptide Versus Insulin: Relationships with Risk Biomarkers of Cardiovascular Disease in Metabolic Syndrome in Young Arab Females [J].
Abdullah, A. ;
Hasan, H. ;
Raigangar, V. ;
Bani-Issa, W. .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012
[2]   Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals [J].
Ahl, Scott ;
Guenther, Mitchell ;
Zhao, Shi ;
James, Roland ;
Marks, Jacqueline ;
Szabo, Aniko ;
Kidambi, Srividya .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (11) :4172-4180
[3]   Are metabolically healthy obese individuals really healthy? [J].
Blueher, Matthias .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (06) :R209-R219
[4]   The distinction of metabolically 'healthy' from 'unhealthy' obese individuals [J].
Blueher, Matthias .
CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (01) :38-43
[5]   Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter? [J].
Blueher, Susann ;
Schwarz, Peter .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (09) :1084-1092
[6]   Novel Insights in the Metabolic Syndrome in Childhood and Adolescence [J].
Bussler, Sarah ;
Penke, Melanie ;
Flemming, Gunter ;
Elhassan, Yasir S. ;
Kratzsch, Juergen ;
Sergeyev, Elena ;
Lipek, Tobias ;
Vogel, Mandy ;
Spielau, Ulrike ;
Koerner, Antje ;
de Giorgis, Tommaso ;
Kiess, Wieland .
HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 (3-4) :181-193
[7]   C-peptide: A predictor of cardiovascular mortality in subjects with established atherosclerotic disease [J].
Cardellini, Marina ;
Farcomeni, Alessio ;
Ballanti, Marta ;
Morelli, Monica ;
Davato, Francesca ;
Cardolini, Iris ;
Grappasonni, Giulia ;
Rizza, Stefano ;
Guglielmi, Valeria ;
Porzio, Ottavia ;
Pecchioli, Chiara ;
Menghini, Rossella ;
Ippoliti, Arnaldo ;
Federici, Massimo .
DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (05) :395-399
[8]   Prevalence of the metabolic syndrome in individuals with hyperuricemia [J].
Choi, Hyon K. ;
Ford, Earl S. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (05) :442-447
[9]   Clinical Characteristics and Metabolic Health Status of Obese Korean Children and Adolescents [J].
Chun, Sunyoung ;
Lee, Saerom ;
Son, Hyo-Jae ;
Noh, Hye-Mi ;
Oh, Hye-Young ;
Jang, Han Byul ;
Lee, Hye-Ja ;
Kang, Jae-Heon ;
Song, Hong-Ji ;
Paek, Yu-Jin ;
Park, Kyung-Hee .
KOREAN JOURNAL OF FAMILY MEDICINE, 2015, 36 (05) :233-238
[10]   Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency [J].
Ciresi, Alessandro ;
Ciccio, Floriana ;
Radellini, Stefano ;
Giordano, Carla .
GROWTH HORMONE & IGF RESEARCH, 2016, 29 :71-77